

House
File
2218
-
Introduced


HOUSE
FILE
2218


BY
COMMITTEE
ON
HUMAN


RESOURCES


(SUCCESSOR
TO
HSB
532)


A
BILL
FOR


An
Act
relating
to
controlled
substances,
including
information
1


collection
and
reporting
requirements
under
the
Iowa
2


prescription
monitoring
program.
3


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
4


TLSB
5333HV
(2)
88


ss/rh



H.F.
2218


Section
1.
Section
124.551,
subsection
2,
paragraph
b,
Code
1


2020,
is
amended
to
read
as
follows:
2


b.
The
information
collected
shall
be
used
by
prescribing
3


practitioners
,
veterinarians,


and
pharmacists
on
a
need-to-know
4


basis
for
purposes
of
improving
patient
health
care
by
5


facilitating
early
identification
of
patients
who
may
be
at
6


risk
for
addiction,
or
who
may
be
using,
abusing,
or
diverting
7


drugs
for
unlawful
or
otherwise
unauthorized
purposes
at
risk
8


to
themselves
and
others,
or
who
may
be
appropriately
using
9


controlled
substances
lawfully
prescribed
for
them
but
unknown
10


to
the
practitioner.
11


Sec.
2.
Section
124.553,
subsection
1,
paragraph
a,
12


subparagraph
(1),
Code
2020,
is
amended
to
read
as
follows:
13


(1)
A
pharmacist
,
veterinarian,


or
prescribing
practitioner
14


who
requests
the
information
and
certifies
in
a
form
specified
15


by
the
board
that
it
is
for
the
purpose
of
providing
medical
16


or
pharmaceutical
care
to
a
patient
of
the
pharmacist
,
17


veterinarian,


or
prescribing
practitioner.
A
pharmacist
,
18


veterinarian,


or
a
prescribing
practitioner
may
delegate
19


program
information
access
to
another
authorized
individual
or
20


agent
only
if
that
individual
or
agent
registers
for
program
21


information
access,
pursuant
to
board
rules,
as
an
agent
of
the
22


pharmacist
,
veterinarian,


or
prescribing
practitioner.
Board
23


rules
shall
identify
the
qualifications
for
a
pharmacist’s
,
24


veterinarian’s,
or
prescribing
practitioner’s
agent
and
25


shall
limit
the
number
of
agents
to
whom
each
pharmacist
,
26


veterinarian,
or
prescribing
practitioner
may
delegate
program
27


information
access.


28


Sec.
3.
Section
124.553,
subsections
5
and
6,
Code
2020,
are


29


amended
to
read
as
follows:
30


5.
Nothing
in
this
section
shall
require
a
pharmacist
,


31


veterinarian,


or
prescribing
practitioner
to
obtain
information
32


about
a
patient
from
the
program.
A
pharmacist
,
veterinarian,
33


or
prescribing
practitioner
does
not
have
a
duty
and
shall
34


not
be
held
liable
in
damages
to
any
person
in
any
civil
or
35


-1-


LSB
5333HV
(2)
88


ss/rh
1/
3


















H.F.
2218


derivative
criminal
or
administrative
action
for
injury,
death,
1


or
loss
to
person
or
property
on
the
basis
that
the
pharmacist
,


2


veterinarian,
or
prescribing
practitioner
did
or
did
not
seek
3


or
obtain
or
use
information
from
the
program.
A
pharmacist
,
4


veterinarian,


or
prescribing
practitioner
acting
reasonably
5


and
in
good
faith
is
immune
from
any
civil,
criminal,
or
6


administrative
liability
that
might
otherwise
be
incurred
or
7


imposed
for
requesting
or
receiving
or
using
information
from
8


the
program.
9


6.
The
board
shall
not
charge
a
fee
to
a
pharmacy,
10


pharmacist,
veterinarian,


or
prescribing
practitioner
for
the
11


establishment,
maintenance,
or
administration
of
the
program,
12


including
costs
for
forms
required
to
submit
information
to
or
13


access
information
from
the
program,
except
that
the
board
may
14


charge
a
fee
to
an
individual
who
requests
the
individual’s
own
15


program
information.
A
fee
charged
pursuant
to
this
subsection
16


shall
not
exceed
the
actual
cost
of
providing
the
requested
17


information
and
shall
be
considered
a
repayment
receipt
as
18


defined
in
section
8.2
.
19


Sec.
4.
Section
124.554,
subsection
1,
paragraph
g,
Code
20


2020,
is
amended
to
read
as
follows:
21


g.
Including
all
schedule
II
,
schedule
III,
and
schedule
IV


22


controlled
substances
,
those
substances
in
schedules
III
and
IV


23


that
the
advisory
council
and
board
determine
can
be
addictive
24


or
fatal
if
not
taken
under
the
proper
care
and
direction
of
25


a
prescribing
practitioner
,
schedule
V
controlled
substances
26


including
when
dispensed
by
a
pharmacist
without
a
prescription
27


except
for
sales
of
pseudoephedrine
that
are
reported
to
the
28


real-time
electronic
repository,
and
opioid
antagonists
,
and
29


other
prescription
substances
that
the
advisory
council
and


30


board
determine
can
be
addictive
or
fatal
if
not
taken
under
31


the
proper
care
and
direction
of
a
prescribing
practitioner


.
32


Sec.
5.
Section
124.554,
subsection
2,
unnumbered
paragraph
33


1,
Code
2020,
is
amended
to
read
as
follows:


34


Beginning
January


February
1,
2007
2021
,
and
annually
by
35


-2-


LSB
5333HV
(2)
88


ss/rh
2/
3


























H.F.
2218


January
February
1
thereafter,
the
board
and
advisory
council
1


shall
present
to
the
general
assembly
and
the
governor
a
2


report
prepared
consistent
with
section
124.555,
subsection
3
,
3


paragraph
“d”
,
which
shall
include
but
not
be
limited
to
the
4


following:
5


Sec.
6.
Section
124.554,
subsection
3,
paragraph
a,
6


unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as
7


follows:
8


Beginning
February
1,
2019,
and
annually


Annually
by
9


February
1
thereafter
,
the
board
shall
electronically,
and
at
10


as
low
a
cost
as
possible,
issue
each
prescribing
practitioner
11


who
prescribed
a
controlled
substance
reported
to
the
program
12


as
dispensed
in
the
preceding
calendar
year
in
this
state
a
13


prescribing
practitioner
activity
report
which
shall
include
14


but
not
be
limited
to
the
following:
15


EXPLANATION
16


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
17


the
explanation’s
substance
by
the
members
of
the
general
assembly.
18


This
bill
relates
to
the
Iowa
prescription
monitoring
19


program
(PMP).
The
bill
allows
veterinarians
to
register
20


for
and
access
information
from
the
PMP.
The
bill
expands
21


PMP
reporting
requirements
to
all
schedule
III
and
schedule
22


IV
controlled
substances
and
to
all
schedule
V
controlled
23


substances
except
for
sales
of
pseudoephedrine
that
are
24


reported
to
the
real-time
electronic
repository.
The
bill
also
25


requires
the
reporting
of
other
prescription
substances
that
26


the
PMP
advisory
council
and
board
of
pharmacy
determine
could
27


be
addictive
or
fatal
if
not
taken
under
the
proper
care
and
28


direction
of
a
prescribing
practitioner.
29


The
bill
changes
the
due
date
for
annual
reports
to
the
30


governor
and
legislature
regarding
the
PMP
from
January
1
to
31


February
1.
32


-3-


LSB
5333HV
(2)
88


ss/rh
3/
3






